@article{0a9ccebb59cd4bf2b8927b71eb347e44,
title = "TAVI with current CE-marked devices: Strategies for optimal sizing and valve delivery",
abstract = "Transcatheter aortic valve implantation (TAVI) has evolved from an exclusive, highly complex and hazardous procedure into a mature, safe and streamlined therapy for patients with severe aortic stenosis (AS). Various successive device iterations and product refinements have created a dynamic and competitive field with a spectrum of different CE-marked transcatheter heart valve (THV) designs. This review provides a practical overview of current CE-marked THVs with a focus on respective sizing algorithms and delivery strategies.",
author = "{Van Gils}, Lennart and Didier Tchetche and Azeem Latib and Carmelo Sgroi and Ganesh Manoharan and Helge M{\"o}llmann and {Van Mieghem}, {Nicolas M.}",
note = "Funding Information: The Erasmus Medical Center has received research grants from Claret Medical, Boston Scientific, Medtronic and Edwards Lifesciences. H. M{\"o}llmann is a speaker and has received proctor honoraria from Abbott, Edwards Lifesciences, St. Jude Medical and Symetis. A. Latib is a consultant for Medtronic and Direct Flow Medical. D. Tchetche is a proctor for Edwards Lifesciences, Boston Scientific and Medtronic. G. Manoharan is a proctor for St. Jude Medical. The other authors have no conflicts of interest to declare. Publisher Copyright: {\textcopyright} Europa Digital & Publishing 2016. All rights reserved.",
year = "2016",
doi = "10.4244/EIJV12SYA6",
language = "English (US)",
volume = "12",
pages = "Y22--Y27",
journal = "EuroIntervention",
issn = "1774-024X",
publisher = "EuroPCR",
}